Generic Name and Formulations:
Olopatadine HCl 0.1%; oph. soln; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for PATANOL:
Treatment of signs and symptoms of allergic conjunctivitis.
Adults and Children:
<3yrs: not recommended. ≥3yrs: 1 drop in affected eye(s) twice daily (6–8 hours apart).
Contact lenses (remove; may reinsert 10 minutes after administration, if eye is not red). Pregnancy (Cat.C). Nursing mothers.
Headache, ocular effects (eg, blurred vision, burning/stinging, dry eye, foreign body sensation, hyperemia, keratitis, lid edema, pruritus), asthenia, cold syndrome, pharyngitis, rhinitis, sinusitis, taste perversion.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- Prevalence of Major Depressive Disorder Remains High In US Population
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Suicide Risk After Self-Harm Among Adolescents, Young Adults
- E-Cigarettes Associated With More Harms Than Benefits at Population Level
- Safety, Efficacy of Deep Brain Stimulation for Alzheimer's
- Many Teens Who Use Tobacco Don't Self-Identify as Users
- Evidence of Methylphenidate Abuse: Characterizing Patterns of Use in Pediatric and Adult Populations